FDA: Hospira Symbiq Infusers Recalled
Motor encoder failures in the pumping mechanism may cause infuser malfunction
FRIDAY, Nov. 5 (HealthDay News) -- The U.S. Food and Drug Administration and Hospira have notified health care professionals of a class I recall of Symbiq one-channel and two-channel infusers due to motor encoder failures in the pumping mechanism that can lead to infuser malfunction.
Symbiq infusers are infusion pumps used for the delivery of fluids by parenteral, enteral, intravenous, intra-arterial, subcutaneous, epidural, or irrigation administration routes. Delay or interruption of therapy may result in serious injury or death to pediatric patients, neonates, or those receiving critical therapy.
The affected units were distributed between Dec. 23, 2006, and Jan. 22, 2010. An FDA recall notice provides a list of affected lots. Hospira is currently upgrading all Symbiq pumping mechanisms; loaner pumps will be provided to customers for critical care areas at no cost until upgraded motors are available.
According to an FDA safety alert, "until loaner or corrected pumps are in place in critical care areas, Hospira urges customers to consider an alternate method to administer therapy."